13 March 2015 Similarities and differences in ablative and non-ablative iron oxide nanoparticle hyperthermia cancer treatment
Author Affiliations +
Abstract
The use of hyperthermia to treat cancer is well studied and has utilized numerous delivery techniques, including microwaves, radio frequency, focused ultrasound, induction heating, infrared radiation, warmed perfusion liquids (combined with chemotherapy), and recently, metallic nanoparticles (NP) activated by near infrared radiation (NIR) and alternating magnetic field (AMF) based platforms. It has been demonstrated by many research groups that ablative temperatures and cytotoxicity can be produced with locally NP-based hyperthermia. Such ablative NP techniques have demonstrated the potential for success. Much attention has also been given to the fact that NP may be administered systemically, resulting in a broader cancer therapy approach, a lower level of tumor NP content and a different type of NP cancer therapy (most likely in the adjuvant setting). To use NP based hyperthermia successfully as a cancer treatment, the technique and its goal must be understood and utilized in the appropriate clinical context. The parameters include, but are not limited to, NP access to the tumor (large vs. small quantity), cancer cell-specific targeting, drug carrying capacity, potential as an ionizing radiation sensitizer, and the material properties (magnetic characteristics, size and charge). In addition to their potential for cytotoxicity, the material properties of the NP must also be optimized for imaging, detection and direction. In this paper we will discuss the differences between, and potential applications for, ablative and non-ablative magnetic nanoparticle hyperthermia.
© (2015) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Alicia A. Petryk, Adwiteeya Misra, Elliot J. Kastner, Courtney M. Mazur, James D. Petryk, P. Jack Hoopes, "Similarities and differences in ablative and non-ablative iron oxide nanoparticle hyperthermia cancer treatment", Proc. SPIE 9326, Energy-based Treatment of Tissue and Assessment VIII, 93260K (13 March 2015); doi: 10.1117/12.2084041; https://doi.org/10.1117/12.2084041
PROCEEDINGS
13 PAGES


SHARE
Back to Top